Canada Markets closed

Aequus Pharmaceuticals Inc. (AQS.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1000-0.0050 (-4.76%)
At close: 3:59PM EDT
Full screen
Previous Close0.1050
Open0.1050
Bid0.0900 x 0
Ask0.1000 x 0
Day's Range0.0950 - 0.1050
52 Week Range0.0650 - 0.1800
Volume51,619
Avg. Volume99,879
Market Cap8.044M
Beta (5Y Monthly)0.35
PE Ratio (TTM)N/A
EPS (TTM)-0.0350
Earnings DateMay 30, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.52
  • CNW Group

    Aequus Completes C$2.5 million Equity Financing

    /NOT FOR DISTRIBUTION TO U. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Aug.

  • CNW Group

    Aequus Announces "Best Efforts" Public Offering

    /NOT FOR DISTRIBUTION TO U. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, July 28, 2020 /CNW/ - Aequus Pharmaceuticals Inc.

  • GlobeNewswire

    Aequus Announces Issuance of Stock Options

    Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today a grant of 1,124,337 stock options to the Chief Operating Officer to replace the same number of previously issued options that expired on May 31, 2020. The terms of the stock options granted on June 4, 2020 are in accordance with the Company’s Stock Option Plan.